RESEARCH PROJECTS

Project Title: Functional impact of epigenetic regulation in hepatocarcinoma: Development of combined nanovectorization of miRNAs/lncRNAs and drugs useful in experimental liver cancer model

Financial Entity: Instituto de Salud Carlos III (PI19/01266)

Lenght: 2020-2022

Principal Investigator: Jordi Muntané Relat

granted: 165.770,00 Euros

 

Network Title: Biología y Medicina Redox

Financial Entity: Convocatoria 2018 ‐ Acciones de dinamización «Redes de Investigación» (RED2018‐102576‐T)

Lenght: 2020-2021

Principal investigator: Juan Sastre Belloch

Granted: 20.500 Euros

 

Project Title: Aislamiento y criopreservación de hepatocitos humanos útiles para la validación de la actividad de los inhibidores de tirosina quinasa en el metabolismo celular y en los mecanismos de supervivencia y muerte celular

Financial Entity: Consejería de Salud y Familias, Convocatoria Proyectos de investigación e innovación colaboración público-privada (PIP-0215-2020)

Lenght: 2021-2023

Principal investigator: Miguel Ángel Gómez Bravo

granted: 243.788,50 Euros

 

Project title: Identificación del papel de miRNA y lncRNA en las células tumorales circulantes en la progresión y respuesta al tratamiento en pacientes con carcinoma hepatocelular en estadio intermedio y avanzado. Desarrollo de una nueva terapia experimental

Financial Entity: Consejería de Salud y Familias, Convocatoria Proyectos de investigación en salud (PI-0216-2020)

Lenght: 2021-2023

Principal Investigator: Jordi Muntané Relat, María Teresa Ferrer Ríos

Granted: 149.508,05 Euros

Project Title: Functional impact of epigenetic regulation in hepatocarcinoma: Development of combined nanovectorization of miRNAs/lncRNAs and drugs useful in experimental liver cancer model

Financial Entity: Instituto de Salud Carlos III (PI19/01266)

Lenght: 2020-2022

Principal Investigator: Jordi Muntané Relat

Granted: 165.770,00 Euros

 

Project Title: Liquid Biopsy applied to the search for cellular and epigenetic markers for the development of diagnostic, prognostic and predictive tests in patients with hepatocarcinoma (PC-0033-2017)

Financial Entity: Consejería de Salud (Junta de Andalucía)

Other collaborating Entity: Genyo (Granada)

Lenght: 2018-2020

Principal Investigator: José Antonio Lorente Acosta

Granted: 66.065,38 Euros

 

Project Title: In vitro 3-D total cell guidance and fitness (COST Action CA16119 CellFit)

Financial Entity: COST Action CA16119

Lenght: 2017-2021

Principal Investigator: Tiziana Brevini

Working groups: WG1 3-D Cultures and Bioprinting; WG3 Chemobiological cues and Epigenetic controls

Countries: Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, fYR Macedonia, Germany, Greece, Hungary, Ireland, Israel, Italy, Netherlands, Poland, Portugal, Serbia, Slovenia, Spain, Switzerland, Turkey, United Kingdom. The Cost includes two enterprises.

Granted: 580.000 Euros

 

Project Title: Genetic, transcriptomic and proteomic markers related to the evolution of hepatocarcinoma, co-morbidities and response to treatments (PI16/00090)

Financial Entity: Instituto de Salud Carlos III

Lenght: 2017-2019

Principal Investigator: Jordi Muntané Relat

Granted: 152.460 Euros

 

Project Title: Extracellular vesicle secretion and its relationship with the evolution of hepatocarcinoma, co-morbidities and response to treatments: Clinical and experimental study (PI-0198-2016)

Financial Entity: Consejería de Salud

Lenght: 2017-2019

Principal Investigator: Raul González Ojeda

Granted: 57.465,49 Euros

 

Project Title: Stratification of patients with hepatocarcinoma based on the detection and genetic and phenotypic analysis of CTCs: relationship with clinical evolution and response to treatment (PC-0522-2016-0043)

Financial Entity: Consejería de Salud

Lenght: 2017-2019

Principal Investigator: José María Álamo

Granted: 16.100 Euros

 

Project Title: European Network of Multidisciplinary Research and Translation of Autophagy knowledge (TRANSAUTOPHAGY)

Financial Entity: COST Action CA15138

Lenght: 2016-2020

Principal Investigator: Caty Casas

Working groups: WG1: Basic Research on Autophagy Molecular Machinery; WG4: Biomedical Research (iv Cancer).

Countries: Austria, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Serbia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom. The Cost includes two enterprises.

Granted: 560.000 Euros

 

Project Title: Mitochondrial mapping: Evolution-Age-Gender-Lifestyle-Environment (MITOEAGLE)

Financial Entity: COST Action CA15203)

Lenght: 2016-2020

Principal Investigator: Erich Gnaiger

Working groups: TG3.2 Liver and TG4.2 Cultured cells.

Countries: Austria, Belgium, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland, United Kingdom, Egipto. The Cost includes two enterprises.

Granted: 540.000 Euros